(Health-NewsWire.Net, July 11, 2016 ) The report "Bioburden Testing Market by Product (Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)), Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019”, provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the bioburden testing market along with estimates and forecasts of the revenue and share analysis.
Browse 96 market data tables and 46 figures spread through 180 pages and in-depth TOC on “Bioburden Testing Market"
http://www.marketsandmarkets.com/Market-Reports/bioburden-testing-market-17983056.html
Early buyers will receive 10% customization on reports.
The global bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, growing at a CAGR of 9.8% from 2014 to 2019.
The report segments the bioburden testing market on the basis of products and services, test types, applications, end users, and regions. In the product segment, consumables accounted for the largest share in 2014; however, the culture media and reagents & kits segment will grow at the highest CAGR during the forecast period as culture media and reagents & kits are most commonly used for bioburden testing. Factors such as the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the bioburden testing market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination are driving the growth of the bioburden testing market.
Download PDF Brochure @
http://www.marketsandmarkets.com/pdfdownload.asp?id=17983056
Based on regions, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in the forecast period.
Get Report Sample @
http://www.marketsandmarkets.com/requestsample.asp?id=17983056
Key players in the bioburden testing market include Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co. Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.).
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com
|